A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Lauren Seeberger, Christopher A. Ross et al.|Neurology|2016Cited by 137
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Hope Heller, Andrew McGarry et al.|The Lancet Neurology|2018Cited by 108
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Lauren Seeberger, Michael McDermott et al.|Unknown|2017Cited by 28